Author | Virginia Kaklamani, MD, University of Texas Health Science Center | OncLive

Author | Virginia Kaklamani, MD, University of Texas Health Science Center

Articles

Dr. Kaklamani on Triple Combination Treatment for Breast and Ovarian Cancer

December 31, 2014

Video

Virginia Kaklamani, MD, a professor of medicine in the Division of Hematology/Oncology at the University of Texas Health Sciences Center at San Antonio, discusses a recent clinical trial that looks at the combination of two chemotherapy drugs, carboplatin and eribulin, along with the PARP inhibitor E7449 for the treatment of breast and ovarian cancer.

x